Antitrypsin Deficiency Stocks List

Antitrypsin Deficiency Stocks Recent News

Date Stock Title
May 10 INBX Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
May 10 BAX A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
May 10 NTLA Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
May 10 NTLA Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
May 10 BAX Baxter downgraded to hold by TD Cowen in wake of selloff
May 10 NTLA Intellia's (NTLA) Q1 Earnings & Revenues Beat Estimates
May 10 NTLA Intellia Therapeutics First Quarter 2024 Earnings: Beats Expectations
May 10 NTLA Q1 2024 Intellia Therapeutics Inc Earnings Call
May 9 KMDA Kamada Ltd. (NASDAQ:KMDA) Q1 2024 Earnings Call Transcript
May 9 NTLA Intellia Therapeutics, Inc. (NTLA) Q1 2024 Earnings Call Transcript
May 9 NTLA Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
May 9 NTLA Intellia Therapeutics GAAP EPS of -$1.12 beats by $0.25, revenue of $28.94M beats by $19.87M
May 9 NTLA Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 9 BEAM Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 8 INBX Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
May 8 KMDA Kamada Ltd. (KMDA) Q1 2024 Earnings Call Transcript
May 8 NTLA Intellia Therapeutics Q1 2024 Earnings Preview
May 8 BEAM Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
May 8 BAX Baxter International First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 8 KMDA Kamada GAAP EPS of $0.04 misses by $0.02, revenue of $37.7M misses by $0.24M
Antitrypsin Deficiency

Antitrypsin Deficiency is a genetic disorder that affects the lungs and liver. It is caused by a deficiency of the protein alpha-1 antitrypsin (AAT), which is produced in the liver and helps protect the lungs from damage. People with Antitrypsin Deficiency are at an increased risk of developing lung diseases such as emphysema and chronic obstructive pulmonary disease (COPD). They may also be at risk of developing liver disease. Treatment for Antitrypsin Deficiency includes lifestyle changes, medications, and in some cases, a liver transplant.

Browse All Tags